Navigation Links
GPDH Assay Kit from Takara Mirus Bio

ProductsGPDH Assay Kit from Takara Mirus Bio
Company Takara Mirus Bio
Item GPDH Assay Kit
Price $504.00
Description The enzyme glycerol 3-phosphate dehydrogenase catalyzes a reversible reaction between dihydroxyacetone phosphate (DHAP) and glycerol 3-phosphate, with NAD as a coenzyme. GPDH activity increases significantly during differentiation of progenitor cells into adipocytes and, thus, the activity of this enzyme has been used as an index for monitoring fat synthesis. The Glycerol 3-Phosphate Dehydrogenase Assay Kit is a 96-well microtiter plate assay designed to measure the activity of GPDH. This kit can be used to either screen differentiation repressors or to study mechanisms regulating differentiation of primary or established cell-line progenitor cells into adipocytes. The procedure involves extracting cells by addition of the Enzyme Extraction Buffer, followed by serial dilution of the extract. The serially diluted extract is added to a 96 well plate that contains substrate solution, and GPDH activity is calculated by measuring the change (decrease) in absorbance at OD340 using a microtiter UV plate reader.

  • Application(s) Measurement of GPDH Activity regulating differentiation of primary or established cell-line progenitor cells into adipocytes • Screening of differentiation repressors
Info Takara Mirus BioTakara Mirus Bio
510 Charmany Drive
Suite 273
Madison, WI 53719 USA

Call Takara Mirus Bio to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-536-4401
Customer Service: (888) 251-6618 or (608) 441-2844
Fax Number: (608) 441-2845
Web Site: http://www.takaramirusbio.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Glutathione-S-Transferase (GST) Colorimetric Assay Kit from Sigma-Aldrich
2. In Vitro Osteogenesis Assay Kit from CHEMICON
3. Mast Cell Degranulation colorimetric Assay Kit from CHEMICON
4. PR Competitor Assay Green from Invitrogen
5. PolarScreen Androgen Receptor Competitor Assay Kit, Red from Molecular Probes (Invitrogen)
6. Hydrogen Peroxide / Peroxidase Fluorometric (resorufin) Assay Kit, Fluoro H2O2 from BACHEM
7. PPARGamma-Competitor Assay Kit Green from Invitrogen
8. Total antioxidant capacity Colorimetric Assay Kit from Neogen Corporation
9. PolarScreen Progesterone Receptor Competitor Assay Kit, Far Red from Molecular Probes (Invitrogen)
10. Total Antioxidant Power Colorimetric Assay Kit from Neogen Corporation
11. NDPase (GDPase, UDPase, ADPase) Assay Kit from Sigma-Aldrich
Breaking Biology News(10 mins):Charles Darwin: More than the origin 2Charles Darwin: More than the origin 3Oceans day at International Climate Change Conference 2Masimo and Oridion Sign Connectivity Agreement to Integrate Capnostream 28TM 2920 Portable Bedside Monitors into the Masimo Patient SafetyNet 28TM 29 54210 1Masimo and Oridion Sign Connectivity Agreement to Integrate Capnostream 28TM 2920 Portable Bedside Monitors into the Masimo Patient SafetyNet 28TM 29 54210 2Masimo and Oridion Sign Connectivity Agreement to Integrate Capnostream 28TM 2920 Portable Bedside Monitors into the Masimo Patient SafetyNet 28TM 29 54210 3Masimo and Oridion Sign Connectivity Agreement to Integrate Capnostream 28TM 2920 Portable Bedside Monitors into the Masimo Patient SafetyNet 28TM 29 54210 4Masimo and Oridion Sign Connectivity Agreement to Integrate Capnostream 28TM 2920 Portable Bedside Monitors into the Masimo Patient SafetyNet 28TM 29 54210 5Masimo and Oridion Sign Connectivity Agreement to Integrate Capnostream 28TM 2920 Portable Bedside Monitors into the Masimo Patient SafetyNet 28TM 29 54210 6HDM Offers Solution to Health Care Fraud Cited by CNN and Health Plan Week 54205 1HDM Offers Solution to Health Care Fraud Cited by CNN and Health Plan Week 54205 2Plasma Protein Therapeutics Association Urges CMS For Appropriate Hospital Outpatient Drug Reimbursement 54200 1Plasma Protein Therapeutics Association Urges CMS For Appropriate Hospital Outpatient Drug Reimbursement 54200 2Plasma Protein Therapeutics Association Urges CMS For Appropriate Hospital Outpatient Drug Reimbursement 54200 3